Pharmaceutical composition and cosmetic composition

US12383583B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12383583-B2
Application numberUS-202418734602-A
CountryUS
Kind codeB2
Filing dateJun 5, 2024
Priority dateNov 7, 2018
Publication dateAug 12, 2025
Grant dateAug 12, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a pharmaceutical composition or a pharmaceutical composition raw material, which contains supernatant from a culture medium used during culture to induce pluripotent stem cells.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for activating secretion of a growth factor of hair papilla cells, comprising: applying to scalp or hair a supernatant of a culture medium, wherein the supernatant of the culture medium is produced by a method comprising culturing somatic cells, introducing genes encoding reprogramming factors into the somatic cells to produce reprogrammed somatic cells, inducing iPS cells (induced pluripotent stem cells) from the reprogrammed somatic cells, and subsequently recovering the supernatant of the culture medium in which the iPS cells were induced. 2. The method of claim 1 , wherein the somatic cells comprise at least one cell selected from the group consisting of a blood cell and a fibroblast. 3. A method for promoting production of a fibroblast growth factor family for hair papilla cells, comprising: applying to scalp or hair a supernatant of a culture medium, wherein the supernatant of the culture medium is produced by a method comprising culturing somatic cells, introducing genes encoding reprogramming factors into the somatic cells to produce reprogrammed somatic cells, inducing iPS cells (induced pluripotent stem cells) from the reprogrammed somatic cells, and subsequently recovering the supernatant of the culture medium in which the iPS cells were induced. 4. The method of claim 3 , wherein the somatic cells comprise at least one cell selected from the group consisting of a blood cell and a fibroblast. 5. A method for promoting production of a vascular endothelial cell growth factor for hair papilla cells, comprising: applying to scalp or hair a supernatant of a culture medium, wherein the supernatant of the culture medium is produced by a method comprising culturing somatic cells, introducing genes encoding reprogramming factors into the somatic cells to produce reprogrammed somatic cells, inducing iPS cells (induced pluripotent stem cells) from the reprogrammed somatic cells, and subsequently recovering the supernatant of the culture medium in which the iPS cells were induced. 6. The method of claim 5 , wherein the somatic cells comprise at least one cell selected from the group consisting of a blood cell and a fibroblast. 7. A method for activating secretion of IGF-1 for hair papilla cells, comprising: applying to scalp or hair a supernatant of a culture medium, wherein the supernatant of the culture medium is produced by a method comprising culturing somatic cells, introducing genes encoding reprogramming factors into the somatic cells to produce reprogrammed somatic cells, inducing iPS cells (induced pluripotent stem cells) from the reprogrammed somatic cells, and subsequently recovering the supernatant of the culture medium in which the iPS cells were induced. 8. The method of claim 7 , wherein the somatic cells comprise at least one cell selected from the group consisting of a blood cell and a fibroblast. 9. A method for improving growth of hair papilla cells, comprising: contacting the hair papilla cells with a composition, wherein the composition comprising a supernatant of a culture medium; and at least one selected from the group consisting of a buffering agent, an emulsifier, a suspending agent, a sedative, a stabilizer, a preservative, an antiseptic, a surfactant, a humectant, a thickener, a natural fat or oil, a skin whitener, a chelating agent, silicon, an antiseptic agent, and a microbicide, wherein the supernatant of the culture medium is produced by a method comprising culturing somatic cells, introducing genes encoding reprogramming factors into the somatic cells to produce reprogrammed somatic cells, inducing iPS cells (induced pluripotent stem cells) from the reprogrammed somatic cells, and subsequently recovering the supernatant of the culture medium in which the iPS cells were induced. 10. A method for activating secretion of a growth factor of hair papilla cells, comprising: applying a composition to scalp or hair, wherein the composition comprising a supernatant of a culture medium; and at least one selected from the group consisting of a buffering agent, an emulsifier, a suspending agent, a sedative, a stabilizer, a preservative, an antiseptic, a surfactant, a humectant, a thickener, a natural fat or oil, a skin whitener, a chelating agent, silicon, an antiseptic agent, and a microbicide, wherein the supernatant of the culture medium is produced by a method comprising culturing somatic cells, introducing genes encoding reprogramming factors into the somatic cells to produce reprogrammed somatic cells, inducing iPS cells (induced pluripotent stem cells) from the reprogrammed somatic cells, and subsequently recovering the supernatant of the culture medium in which the iPS cells were induced. 11. A method for promoting production of a fibroblast growth factor family for hair papilla cells, comprising: applying a composition, wherein the composition comprising a supernatant of a culture medium; and at least one selected from the group consisting of a buffering agent, an emulsifier, a suspending agent, a sedative, a stabilizer, a preservative, an antiseptic, a surfactant, a humectant, a thickener, a natural fat or oil, a skin whitener, a chelating agent, silicon, an antiseptic agent, and a microbicide, wherein the supernatant of the culture medium is produced by a method comprising culturing somatic cells, introducing genes encoding reprogramming factors into the somatic cells to produce reprogrammed somatic cells, inducing iPS cells (induced pluripotent stem cells) from the reprogrammed somatic cells, and subsequently recovering the supernatant of the culture medium in which the iPS cells were induced to scalp or hair, wherein the composition comprising a supernatant of a culture medium; and at least one selected from the group consisting of a buffering agent, an emulsifier, a suspending agent, a sedative, a stabilizer, a preservative, an antiseptic, a surfactant, a humectant, a thickener, a natural fat or oil, a skin whitener, a chelating agent, silicon, an antiseptic agent, and a microbicide, wherein the supernatant of the culture medium is produced by a method comprising culturing somatic cells, introducing genes encoding reprogramming factors into the somatic cells to produce reprogrammed somatic cells, inducing iPS cells (induced pluripotent stem cells) from the reprogrammed somatic cells, and subsequently recovering the supernatant of the culture medium in which the iPS cells were induced. 12. A method for promoting production of a vascular endothelial cell growth factor for hair papilla cells, comprising: applying a composition to scalp or hair, wherein the composition comprising a supernatant of a culture medium; and at least one selected from the group consisting of a buffering agent, an emulsifier, a suspending agent, a sedative, a stabilizer, a preservative, an antiseptic, a surfactant, a humectant, a thickener, a natural fat or oil, a skin whitener, a chelating agent, silicon, an antiseptic agent, and a microbicide, wherein the supernatant of the culture medium is produced by a method comprising culturing somatic cells, introducing genes encoding reprogramming factors into the somatic cells to produce reprogrammed somatic cells, inducing iPS cells (induced pluripotent stem cells) from the reprogrammed somatic cells, and subsequently recovering the supernatant of the culture medium in which the iPS cells were induced. 13. A method for activating secretion of IGF- 1 for hair papilla cells, comprising: applying a composition, wherein the composition comprising a supernatant of a culture medium; and at least one selected from the group consisting of a buffering agent, an emulsifier, a suspending agen

Assignees

Inventors

Classifications

  • Anti-ageing preparations · CPC title

  • Reproductive organs; Embryos, Eggs · CPC title

  • A61P17/14Primary

    for baldness or alopecia · CPC title

  • Preparations for affecting hair growth · CPC title

  • A61K35/545Primary

    Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12383583B2 cover?
Provided are a pharmaceutical composition or a pharmaceutical composition raw material, which contains supernatant from a culture medium used during culture to induce pluripotent stem cells.
Who is the assignee on this patent?
Tanabe Koji, I Peace Inc
What technology area does this patent fall under?
Primary CPC classification A61P17/14. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).